NCT02584933 2026-02-03
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
Clinical Trials
27 trialsNCT04362072 2025-06-11
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Pfizer
Phase 4 Completed
NCT02312960 2025-03-25
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Phase 4 Completed
NCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
NCT03333655 2022-08-12
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy
Hoffmann-La Roche
Phase 4 Completed
NCT02426034 2022-07-01
A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 4 Completed
NCT01739764 2021-01-07
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Hoffmann-La Roche
Phase 4 Completed
NCT01588184 2020-11-05
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
Hoffmann-La Roche
Phase 4 Completed
NCT04261920 2020-03-09
Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction
Jiangsu Famous Medical Technology Co., Ltd.
Phase 4 Unknown
NCT03831633 2019-02-06
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
VIFORFRANCE
Phase 4 Unknown
NCT00198276 2017-10-03
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Inovio Pharmaceuticals
Phase 4 Completed
NCT00241111 2017-03-06
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
Novartis
Phase 4 Completed
NCT02088515 2017-03-03
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4 Completed
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01675531 2016-12-16
A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Mundipharma Korea Ltd
Phase 4 Completed
NCT00944372 2016-09-09
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
Mallinckrodt
Phase 4 Terminated
NCT01328054 2016-06-08
A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
GlaxoSmithKline
Phase 4 Completed
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01968018 2013-10-23
A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain
Janssen-Cilag Ltd.,Thailand
Phase 4 Completed
NCT01107756 2012-10-05
Grano-Tax
Sanofi
Phase 4 Completed
NCT01318473 2012-10-03
ActiSight
ActiViews Ltd.
Phase 4 Completed
NCT01040884 2012-07-12
Safety And Accuracy Study Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Procedures
ActiViews Ltd.
Phase 4 Completed
NCT01205230 2012-05-22
VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
GlaxoSmithKline
Phase 4 Completed
NCT00894153 2012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00902083 2012-04-09
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00606515 2009-02-10
LPS-PK-H
Shandong Luye Pharmaceutical Co., Ltd.
Phase 4 Completed